Climate change and global warming have imposed new logistical challenges on the so-called Cold Chain, according to a report by the Grand View Research, the market for refrigerated or refrigerated products is expected to reach US$ 892.27 billion by 2030, growing at an annual rate of 19.2% from 2025. At the same time, extreme temperature fluctuations can compromise the integrity of sensitive items such as food, vaccines and hospital supplies.
This context has demanded new technological solutions, such as temperature monitoring sensors along the logistics chain, in order to ensure quality control and avoid losses.
Specialist in logistics risk management, a AHM Solution it has part of its operations focused on the Cold Chain.“Among the solutions we offer are sensors that allow real-time monitoring of thermal conditions during transport and storage, ensuring compliance with regulatory standards and the integrity of” products, explains Afonso Moreira, CEO of the company.
The systems provided by AHM Solution automatically alert the loaders in case of deviations from the temperature recommended by the manufacturer, allowing quick actions to avoid losses.
“In addition, the registers provide data on performance and temperature history during all stages of the logistics chain, assisting in strategic decision making, which can even impact changes in the” transport network, Moreira adds.
One of the activities that require strict full-time temperature control is the logistics of organ or blood donation. In the case of organs, transportation needs to take place in a thermal box that maintains temperatures between 2 and 8°C. If it falls below or above that, the item needs to be discarded & something that is not uncommon. According to a study from the Ministry of Health and the Foundation for Teaching and Research in Health Sciences (Fepecs), of the 22,824 organs available between 2014 and 2021, about 60% were not used due to lack of adequate conditions.
In the case of blood bags, according to Anvisa (National Agency for Health Surveillance), enter 10% and 20% they are discarded, mainly due to conservation failures and contamination.
Last year, a new temperature indicator device received certification from the FDA (Food and Drug Administration), a health surveillance agency in the United States.HemoTemp II has an irreversible temperature sensor that warns the user when the temperature of the blood bag is above 6°C. In Brazil, this solution is represented by the AHM Solution.
“Strict temperature control throughout the Cold Chain is not only a regulatory requirement, but a vital need to preserve lives and avoid waste.In times of global warming, the use of advanced technologies becomes imperative to ensure the efficiency and sustainability of these” operations, says the CEO of AHM Solution.